{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:38:12Z","timestamp":1791599892952,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.schres.2023.03.028","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:46:30Z","timestamp":1678988790000},"page":"9-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Long-term effects of Roluperidone on negative symptoms of schizophrenia"],"prefix":"10.1016","volume":"255","author":[{"given":"Jonathan","family":"Rabinowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Staner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Saoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramana","family":"Kuchibhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Luthringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2023.03.028_bb0005","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20f13804","article-title":"HARKing, cherry-picking, P-hacking, fishing expeditions, and data dredging and mining as questionable research practices","volume":"82","author":"Andrade","year":"2021","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2023.03.028_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","article-title":"Bitopertin in negative symptoms of schizophrenia-results from the phase III FlashLyte and DayLyte studies","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2023.03.028_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1037\/mot0000159","article-title":"Effort in daily life: relationships between experimental tasks and daily experience","volume":"6","author":"Culbreth","year":"2020","journal-title":"Motiv. Sci."},{"issue":"12","key":"10.1016\/j.schres.2023.03.028_bb0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/appi.ajp.2017.17010122","article-title":"Efficacy and safety of MIN-101: a 12-week randomized, double-blind, placebo-controlled trial of a new drug in development for the treatment of negative symptoms in schizophrenia","volume":"174","author":"Davidson","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2023.03.028_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/sbac013","article-title":"Efficacy and safety of roluperidone for the treatment of negative symptoms of schizophrenia","volume":"48","author":"Davidson","year":"2022","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2023.03.028_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0269881114562092","article-title":"Dissecting negative symptoms in schizophrenia: opportunities for translation into new treatments","volume":"29","author":"Foussias","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2023.03.028_bb0035","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2023.03.028_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.13049su1c.01","article-title":"Developing concepts in negative symptoms: primary vs secondary and apathy vs expression","volume":"75","author":"Kirkpatrick","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.03.028_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.schres.2022.01.053","article-title":"Reconceptualizing schizophrenia in the Hierarchical Taxonomy Of Psychopathology (HiTOP)","volume":"242","author":"Kotov","year":"2022","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2023.03.028_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgz001","article-title":"Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia: consensus statements","volume":"1","author":"Marder","year":"2020","journal-title":"Schizophr.Bull.Open"},{"issue":"5","key":"10.1016\/j.schres.2023.03.028_bb0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.euroneuro.2014.03.008","article-title":"Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment","volume":"24","author":"Millan","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2023.03.028_bb0060","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.03.028_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2019.07.029","article-title":"Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: results from an exploratory outcome of a randomized placebo-controlled trial","volume":"211","author":"Rabinowitz","year":"2019","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2023.03.028_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2006.12.013","article-title":"The course of schizophrenia: progressive deterioration, amelioration or both?","volume":"91","author":"Rabinowitz","year":"2007","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2023.03.028_bb0075","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/schbul\/sbz141","article-title":"Network analysis indicates that avolition is the Most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial","volume":"46","author":"Strauss","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2023.03.028_bb0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1515\/revneuro-2017-0091","article-title":"Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?","volume":"29","author":"Szczypinski","year":"2018","journal-title":"Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.schres.2023.03.028_bb0085","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.4088\/JCP.11m07031","article-title":"A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia","volume":"73","author":"Weiser","year":"2012","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:51:15Z","timestamp":1760298675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":17,"alternative-id":["S0920996423001226"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.03.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of Roluperidone on negative symptoms of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}